New Street Research Begins Coverage on Pinduoduo (NASDAQ:PDD)

New Street Research Begins Coverage on Pinduoduo (NASDAQ:PDD)

New Street Research assumed coverage on shares of Pinduoduo (NASDAQ:PDD) in a research report report published on Thursday morning, The Fly reports. The firm issued a buy rating on the stock. Other equities research analysts have also... 
Insider Selling: Tabula Rasa HealthCare Inc (NASDAQ:TRHC) President Sells $386,640.00 in Stock

Insider Selling: Tabula Rasa HealthCare Inc (NASDAQ:TRHC) President Sells $386,640.00 in Stock

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) President Orsula V. Knowlton sold 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 18th. The stock was sold at an average price of $48.33, for a total... 
Barclays Boosts Qiagen (NYSE:QGEN) Price Target to $45.00

Barclays Boosts Qiagen (NYSE:QGEN) Price Target to $45.00

Qiagen (NYSE:QGEN) had its target price lifted by Barclays from $43.00 to $45.00 in a research note released on Friday morning, The Fly reports. They currently have an overweight rating on the stock. A number of other research analysts... 
Coliseum Capital Management, L Purchases 100,000 Shares of Lazydays Holdings Inc (NASDAQ:LAZY) Stock

Coliseum Capital Management, L Purchases 100,000 Shares of Lazydays Holdings Inc (NASDAQ:LAZY) Stock

Lazydays Holdings Inc (NASDAQ:LAZY) Director Coliseum Capital Management, L acquired 100,000 shares of the business’s stock in a transaction dated Wednesday, June 19th. The stock was purchased at an average price of $5.25 per... 
Iterum Therapeutics (NASDAQ:ITRM) Research Coverage Started at HC Wainwright

Iterum Therapeutics (NASDAQ:ITRM) Research Coverage Started at HC Wainwright

HC Wainwright assumed coverage on shares of Iterum Therapeutics (NASDAQ:ITRM) in a research note issued to investors on Friday, AnalystRatings.com reports. The brokerage issued a buy rating and a $17.00 price objective on the stock.... 
Tribune Publishing (NASDAQ:TPCO) Lifted to “Hold” at Zacks Investment Research

Tribune Publishing (NASDAQ:TPCO) Lifted to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Tribune Publishing (NASDAQ:TPCO) from a sell rating to a hold rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Tribune Publishing Company is a media company.... 
Sabra Health Care REIT (NASDAQ:SBRA) Lifted to Hold at Zacks Investment Research

Sabra Health Care REIT (NASDAQ:SBRA) Lifted to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Sabra Health Care REIT (NASDAQ:SBRA) from a sell rating to a hold rating in a research note issued to investors on Friday morning, Zacks.com reports. According to Zacks, “Sabra Health... 
Royal Bank of Canada (NYSE:RY) Downgraded by Zacks Investment Research

Royal Bank of Canada (NYSE:RY) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Royal Bank of Canada (NYSE:RY) (TSE:RY) from a hold rating to a sell rating in a research note published on Friday morning, Zacks.com reports. According to Zacks, “ROYAL BANK of Canada... 
Capital Bancorp (NASDAQ:CBNK) Downgraded to “Sell” at Zacks Investment Research

Capital Bancorp (NASDAQ:CBNK) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research cut shares of Capital Bancorp (NASDAQ:CBNK) from a hold rating to a sell rating in a research note published on Thursday morning, Zacks.com reports. According to Zacks, “Capital Bancorp Inc. is a bank... 
Bruker (NASDAQ:BRKR) Rating Reiterated by Bank of America

Bruker (NASDAQ:BRKR) Rating Reiterated by Bank of America

Bank of America reissued their neutral rating on shares of Bruker (NASDAQ:BRKR) in a research report released on Friday morning, Briefing.com Automated Import reports. The brokerage currently has a $52.00 price objective on the medical... 
Axovant Gene Therapies (NASDAQ:AXGT) Research Coverage Started at Svb Leerink

Axovant Gene Therapies (NASDAQ:AXGT) Research Coverage Started at Svb Leerink

Svb Leerink started coverage on shares of Axovant Gene Therapies (NASDAQ:AXGT) in a research note published on Friday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $18.00 target price on the stock. Svb Leerink... 
Crocs (NASDAQ:CROX) Lifted to Outperform at Robert W. Baird

Crocs (NASDAQ:CROX) Lifted to Outperform at Robert W. Baird

Robert W. Baird upgraded shares of Crocs (NASDAQ:CROX) from a neutral rating to an outperform rating in a research note issued to investors on Friday, Benzinga reports. Robert W. Baird currently has $29.00 target price on the textile... 
ValuEngine Upgrades DexCom (NASDAQ:DXCM) to Strong-Buy

ValuEngine Upgrades DexCom (NASDAQ:DXCM) to Strong-Buy

ValuEngine upgraded shares of DexCom (NASDAQ:DXCM) from a buy rating to a strong-buy rating in a research report report published on Friday, ValuEngine reports. Other analysts have also recently issued reports about the stock. BidaskClub... 
LPL Financial (NASDAQ:LPLA) Stock Rating Lowered by BidaskClub

LPL Financial (NASDAQ:LPLA) Stock Rating Lowered by BidaskClub

LPL Financial (NASDAQ:LPLA) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Saturday, BidAskClub reports. Other equities research analysts have also issued... 
Insider Selling: Zscaler Inc (NASDAQ:ZS) EVP Sells 18,000 Shares of Stock

Insider Selling: Zscaler Inc (NASDAQ:ZS) EVP Sells 18,000 Shares of Stock

Zscaler Inc (NASDAQ:ZS) EVP Amit Sinha sold 18,000 shares of the stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $80.78, for a total value of $1,454,040.00. The sale was disclosed...